Clinical trial Recruiting at 1 site Interventional Women only

Postpartum blood sugar screening after gestational diabetes

Official title: Strategies for Improving the Detection of Dysglycemia in the Postpartum Period in Women With Gestational Diabetes: Electronic Reminders and New Diagnostic Criteria

Run by University of Sao Paulo General Hospital · NCT07489456 · Data updated 2026-11-12

This study will test whether WhatsApp reminders help women who had gestational diabetes attend a 75g OGTT at 6–12 weeks postpartum and whether the 1-hour glucose measure detects more cases of dysglycemia than the 2-hour measure.

Quick facts

Study typeInterventional
SexWomen only
Enrollment182 (estimated)
SponsorUniversity of Sao Paulo General Hospital
Academic / other
Locations1 site (São Paulo, São Paulo)
StatusRecruiting
StartedMarch 24, 2026
Main results expectedNovember 2026
Study endsNovember 2026
Registry record updatedMay 4, 2026
Trial IDNCT07489456 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women diagnosed with gestational diabetes by IADPSG criteria who delivered at HC-FMUSP, can schedule a 75g OGTT 6–12 weeks after delivery, and provide informed consent are eligible.

Probably not a fit

Women who withdraw consent, cannot receive or respond to WhatsApp messages, or who cannot complete the OGTT (for example due to vomiting) are unlikely to benefit from the intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Women diagnosed with gestational diabetes at the University of Sao Paulo General Hospital will be scheduled for a 75g oral glucose tolerance test between six and 12 weeks after delivery. The intervention uses WhatsApp reminders to try to increase attendance for the OGTT compared with usual care. During the OGTT the team will record fasting, 1-hour, and 2-hour glucose values to compare how often the 1-hour versus 2-hour measurements identify dysglycemia. Data will be analyzed to quantify any change in attendance and the relative detection rates of postpartum dysglycemia using the different time points.

Why it matters

Potential benefit: If successful, this approach could increase postpartum OGTT attendance and lead to earlier detection of prediabetes or type 2 diabetes after gestational diabetes.

How similar studies have gone: Previous research has shown electronic reminders can improve clinic attendance and some studies suggest the 1-hour OGTT glucose may be more sensitive than the 2-hour value for early postpartum dysglycemia, so this project builds on existing evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of gestational diabetes mellitus, according to diagnostic criteria proposed by the IADPSG, namely:
* initial fasting blood glucose ≥ 92mg/dL OR
* 75g oral glucose tolerance test with fasting ≥ 92mg/dL or after 1h ≥ 180mg/dL or after 2h ≥ 153mg/dL Delivery performed at HC-FMUSP Scheduling of the 75g oral glucose tolerance test between 6 and 12 weeks after delivery Agreement with the informed consent form

Exclusion Criteria:

Withdrawal of consent Failure to complete the TOTG exam due to vomiting (exclusion from analysis 2 only)

Where it's running

  • University of Sao Paulo General Hospital
    São Paulo, São Paulo, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.